Navigation Links
Northwestern Memorial trial may wean kidney transplant patients off antirejection drugs
Date:1/23/2008

CHICAGO After a transplant surgery, anti-rejection drugs for the organ recipient are a must, but with prolonged use can have serious side effects, including infections, heart disease and cancer. A team led by Joshua Miller, MD, a researcher at Northwestern Universitys Feinberg School of Medicine, is working with Northwestern Memorial Hospitals department of organ transplantation to enroll qualifying subjects in a new research study that seeks to transplant stem cells from a kidney donors bone marrow into the recipient, with the hope of gradually eliminating the need for anti-rejection drugs. If research proves successful, it would mean a dramatic change in the post-transplant quality of life for the transplant recipient.

Northwestern is the only center in Chicago and one of four centers nationally looking at this topic. The Feinberg School of Medicine has received a four-year, $2.5 million grant from the National Institutes of Health to enroll 20 patients in the study, which is called "Donor Stem Cells, Campath, T/B Cell Regulation In HLA-Identical Renal Transplants."

The first subjects to participate in the study underwent kidney transplant surgery on Thursday, Jan. 10. Sharon Flood of Pingree Grove, Ill. donated her kidney to her brother Steven Yelk of Gurnee, Ill., who suffers from polycystic kidney disease (PKD), which causes cysts filled with fluid to form throughout the kidneys. Eventually, these cysts take over the healthy kidney tissue and the kidneys fail. Our family is very close and there are seven brothers and sisters, I was thrilled to learn that I was a match and would be able to help Steven, Sharon commented before the surgery.

Joseph Leventhal, MD, PhD, transplant surgeon, associate professor of surgery and director of the Living Donor Renal Transplant Program at Northwestern Universitys Feinberg School of Medicine, preformed the kidney donors surgery and Michael Abecassis, MD, MBA, chief of the division of transpl
'/>"/>

Contact: Amy Dobrozsi
adobrozs@nmh.org
312-926-5900
Northwestern Memorial Hospital
Source:Eurekalert

2

GOOD

Page: 1 2 3

Related biology news :

1. Northwestern study looks at sensing, movement and behavior
2. Northwestern to expose most deadly infectious diseases in 3-D
3. Researchers at Sarasota Memorial Health Care System to study airway bypass treatment for emphysema
4. Nucleonics initiates hepatitis B clinical trial with expressed interfering RNA therapeutic
5. New clinical trial results show how personalized medicine will alter treatment of genetic disorders
6. New model revises estimates of terrestrial carbon dioxide uptake
7. Study of African traditional medicine will begin world-first clinical trial
8. Small-scale fishing in Mexico rivals industrial fisheries in accidental turtle deaths
9. Contrast agent trials in swine
10. The industrial space age
11. Trial seeks genetic fingerprint for predicting drug effectiveness

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...linchpin of the environment, where atmosphere, bio...tudents see soil as "just dirt" a place to grow p...e challenged with the task of helping students and...oil in the environment. , A collaborative proje...niversity of Nebraska-Lincoln, Oregon State Univer...
(Date:11/25/2009)...tal to your health as what you eat, found research...Their experiments in mice revealed that the daily ...erthe body,s metabolic clearinghouseis mostly cont...ian clock as conventional wisdom had it. , "If ...mber of genes completely independent of the circad...
(Date:11/24/2009)...standing how sounds associated with Navy sonar mig...ey hear it at all. , The same type of large indu...ct flaws in the space shuttle,s behemoth solid fue...e the giant head of a whale. The scans are providi...s hearing anatomy using a breakthrough method deve...
Breaking Biology News(10 mins):It's not just dirt! 2Feeding the clock 2Feeding the clock 3Rocket science leads to new whale discovery 2Creighton University St Josephs Hospital and Medical Center Announce New School of Medicine Campus in Phoenix 50434 1Creighton University St Josephs Hospital and Medical Center Announce New School of Medicine Campus in Phoenix 50434 2Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain 12852 1Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain 12852 2Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain 12852 3Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain 12852 4Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain 12852 5Obese Get Higher Doses of Radiation for X Rays 50432 1Obese Get Higher Doses of Radiation for X Rays 50432 2Obese Get Higher Doses of Radiation for X Rays 50432 3
...like a modern-day version of the David and Goliath...slay a big killer with pebbles. In this case, the ...ase: cancer. And the pebbles are not the kind you ...ads known as Photonic Explorers for Biomedical use..., First developed as sensors to explore and monito...
...al School geneticists have found links in the cell... avenues for studying and targeting a process vita...immune diseases. , The work, reported in the Febr...mitochondria, the cellular power plant, in prompti...y cell death models along the evolutionary spectru...
...ffymetrix, Inc. (Nasdaq: AFFX) reported today in S...high-resolution scan of structure and function for...n collaboration with the National Cancer Institute...microarrays to study every fifth base, on average,...s of regions of the genome are transcribed into ov...
Other Biology News:Taking Aim With Nanoparticle PEBBLEs 2Taking Aim With Nanoparticle PEBBLEs 3Critical role in programmed cell death identified 2Critical role in programmed cell death identified 3New Study from Affymetrix Laboratories Points to Changing View of How Genome Works 2New Study from Affymetrix Laboratories Points to Changing View of How Genome Works 3
(Date:11/27/2009)...lue dye test alternative is helping bring complet...ep closer for pharma-companies. It is a non-destru...d by Sepha for use with blister packs and it has...l pharma-companies such as Sanofi-Avenis and Zydus...vity improvements on the packaging line. Blister...
(Date:11/25/2009)...A RATON, Fla., Nov. 25 For many bu... BodyLogicMD. The nation,s largest and fastest gr...clusively in medically supervised bioidentical ho...its network since November 2008 - from 21 to 36...ician-owned centers, including one in Puerto Rico,...
(Date:11/24/2009)... , Whether it,s CD packaging, containers or ...dentification) are increasingly finding their way ... objects or goods and identify them automatically ...ad and process the data contained in the label. Sm...n conditions of up to 100 degrees Celsius. But at ...
(Date:11/24/2009)..., Nov. 24 Dow AgroScienc...ts of Hyland Seeds, a division of Thompsons Limite...ds will further expand Dow AgroSciences, current s...duction of SmartStax(TM) in 2010 and Dow Agr...orn in 2012. The transactional close is expected i...
Breaking Biology Technology:Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Intelligence inside metal components 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...f., Sept. 10 Forterus,Inc. (OTC Bulletin Board: F...ent Center Inc., its behavioral healthcare subsidi...ry, a DNA-customized program for,individuals with ... "As one of the leading addiction treatment center...triving to improve its success rate with,addiction...
.... 10 SoluBest Ltd., a privately,held, clinical st...has,appointed Michael Sheckler, MBA, as CEO. Mr. S...erience to SoluBest., (Logo: http://www.newscom....kler began his career with the Ross Division of Ab...eutical products. During his,time there, he served...
...gy to Identify a New Generation of Drug Candidates... LONDON and CAMBRIDGE, England and PHILADELPHIA an...and GlaxoSmithKline (LSE & NYSE:,GSK) announce the...over,develop and market novel kinase-targeted ther...iance gives GSK access to Cellzome,s significant e...
Other Biology Technology:A Better Tomorrow Treatment Center Inc., Forterus Inc.'s Behavioral Healthcare Subsidiary, is the First in the Nation to Offer DNA-Customized Treatment for Individuals with a Genetic Predisposition for Addictive Behavior 2SoluBest Appoints Michael Sheckler, MBA, as CEO 2GlaxoSmithKline and Cellzome Announce Major Strategic Alliance 2GlaxoSmithKline and Cellzome Announce Major Strategic Alliance 3GlaxoSmithKline and Cellzome Announce Major Strategic Alliance 4
Mouse Anti-Quail cell marker Antibody, Unconjugated from Developmental Studies Hybridoma Bank
...AXIMA-CFR provides a combination of high mass accu...offers excellent versatility with both linear and ...ented curved field reflectron enables the generati...ical peptide fragmentation data for protein identi...
...egory for MALDI. It is based on an orthogonal plat...X joint venture from the University of Manitoba. ,...ter with an orthogonal design and collisional cool... forward from conventional MALDI-TOF in mass accur...
RLF (R506-05) from European Collection of Cell Cultures (ECACC)
Biology Products: